SG Americas Securities’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $442K | Sell |
25,301
-11,125
| -31% | -$194K | ﹤0.01% | 1593 |
|
|
2025
Q1 | $458K | Sell |
36,426
-14,776
| -29% | -$186K | ﹤0.01% | 1663 |
|
|
2024
Q4 | $540K | Sell |
51,202
-7,102
| -12% | -$74.9K | ﹤0.01% | 1097 |
|
|
2024
Q3 | $845K | Sell |
58,304
-53,288
| -48% | -$772K | ﹤0.01% | 1063 |
|
|
2024
Q2 | $950K | Buy |
111,592
+99,986
| +862% | +$851K | 0.01% | 1218 |
|
|
2024
Q1 | $119K | Buy |
+11,606
| New | +$119K | ﹤0.01% | 2148 |
|
|
2022
Q1 | – | Sell |
-11,405
| Closed | -$76K | – | 2942 |
|
|
2021
Q4 | $76K | Sell |
11,405
-2,053
| -15% | -$13.7K | ﹤0.01% | 2827 |
|
|
2021
Q3 | $134K | Buy |
13,458
+6,917
| +106% | +$68.9K | ﹤0.01% | 3235 |
|
|
2021
Q2 | $202K | Buy |
+6,541
| New | +$202K | ﹤0.01% | 2108 |
|
|
2021
Q1 | – | Sell |
-12,900
| Closed | -$598K | – | 3012 |
|
|
2020
Q4 | $598K | Buy |
+12,900
| New | +$598K | ﹤0.01% | 1622 |
|